BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Drug Development

  OKYO Pharma Announces Promising Categorical Data from OK-101 Phase 2 Trial in Dry Eye Disease

  July 10, 2024

   · 

  6 min read
• Business

  Moderna to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024

  July 10, 2024

   · 

  1 min read
• Press Releases

  FDA Grants PharmassêtX Orphan Drug Designation for Treatment of Rare Form of Inflammatory Bowel Disease with Active Component from Green Tea

  July 10, 2024

   · 

  7 min read
• News

  Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95

  July 10, 2024

   · 

  4 min read
• News

  Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results

  July 10, 2024

   · 

  1 min read
• Drug Development

  eNeuro Publishes Findings on the Anti-Convulsant Properties of OV329 and Its Potential Effectiveness in Treatment-Resistant Seizures

  July 10, 2024

   · 

  8 min read
• News

  CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet

  July 10, 2024

   · 

  10 min read
• Business

  Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 09, 2024

  July 10, 2024

   · 

  2 min read
• Deals

  Nusano and PharmaLogic Announce Strategic Supply Agreement to Enable Current and Emerging Radiopharmaceuticals

  July 10, 2024

   · 

  3 min read
• Antonin (Tony) de Fougerolles appointed as new Chair of etherna

  July 10, 2024

   · 

  3 min read